Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of irinotecan + cisplatin in metastatic unresectable esophageal cancer
KCT0000670Phase 2Recruiting
- Sponsor
- National Institute of Food and Drug Safety Evaluation
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan and cisplatin in esophageal cancer, sponsored by National Institute of Food and Drug Safety Evaluation. Started Sep 2013; status: recruiting.
02
Drugs
irinotecancisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on KCT0000670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000670.